Status: Not yet recruiting
Selective Activation of the Adrenomedullin Receptors in Migraine
Adrenomedullin is a neuropeptide implicated in the pathogenesis of migraine. This study investigates whether its administration, after pre-treatment with erenumab (a CGRP-receptor blocking monoclonal antibody), can trigger migraine attacks in individuals with migraine without aura.
Participants needed: 26
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Danish Headache CenterUpdated: Mar 9, 2026Locations: 1
Eligibility criteria
Written informed consent has been obtained prior to the initiation of any study-... [+2]
History of any other primary headache disorder, except for tension-type headache... [+9]